| Name | Southwestern Eye Center |
|---|---|
| Organization Name | Southwestern Eye Center, Ltd |
| Location | 1055 S Stapley Dr, Mesa, Arizona 85204 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (480) 833-9100 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Doxycycline, an antibiotic derivative of tetracycline, commonly results in adverse gastrointestinal side effects and increased liver enzyme activity in cats, report German researchers.
With the 2010 election over and new Capitol Hill leadership arriving in 2011, it is important to continue the discussion about patient-centered health care. In a sustained effort to seek consensus-driven policies that would build a high-value health care system, the Mayo Clinic Health Policy Center will host a symposium Dec. 5 entitled Achieving the Vision: Advancing High-Value Health Care.
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change.
› Verified 3 days ago
| NPI Number | 1881919967 |
| Organization Name | SOUTHWESTERN EYE CENTER LTD |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1055 S Stapley Dr, Mesa, AZ 85204 |
| Phone Number | 480-833-9100 |
News Archive
Doxycycline, an antibiotic derivative of tetracycline, commonly results in adverse gastrointestinal side effects and increased liver enzyme activity in cats, report German researchers.
With the 2010 election over and new Capitol Hill leadership arriving in 2011, it is important to continue the discussion about patient-centered health care. In a sustained effort to seek consensus-driven policies that would build a high-value health care system, the Mayo Clinic Health Policy Center will host a symposium Dec. 5 entitled Achieving the Vision: Advancing High-Value Health Care.
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change.
› Verified 3 days ago
News Archive
Doxycycline, an antibiotic derivative of tetracycline, commonly results in adverse gastrointestinal side effects and increased liver enzyme activity in cats, report German researchers.
With the 2010 election over and new Capitol Hill leadership arriving in 2011, it is important to continue the discussion about patient-centered health care. In a sustained effort to seek consensus-driven policies that would build a high-value health care system, the Mayo Clinic Health Policy Center will host a symposium Dec. 5 entitled Achieving the Vision: Advancing High-Value Health Care.
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change.
› Verified 3 days ago
Osco Drug #0980 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1951 W Baseline Rd, Mesa, Arizona 85202 Phone: (480) 456-4850 | |
Osco Drug #1002 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9243 E Baseline Rd, Mesa, Arizona 85209 Phone: (480) 986-4660 | |
Osco Drug #1948 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 441 N Val Vista Dr, Mesa, Arizona 85213 Phone: (480) 830-5185 | |
Osco Drug #3989 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2727 N Power Rd, Mesa, Arizona 85215 Phone: (480) 396-3838 | |
Osco Pharmacy # 958 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 325 S Power Rd, Mesa, Arizona 85206 Phone: (480) 924-8928 |